History of infusion reactions to any component/excipient of PRS-343.
Known hypersensitivity to any study related agent excipient(s)
History of hypersensitivity to tremelimumab, durvalumab, or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to tremelimumab or any excipient
Has a history of hypersensitivity to durvalumab or tremelimumab excipient
History of hypersensitivity to durvalumab, tremelimumab or any excipient.
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to the combination of durvalumab and tremelimumab.
History of hypersensitivity to durvalumab or any excipient
Known hypersensitivity to ST2210 (DOTA biotin) or any excipient.
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or tremelimumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to tremelimumab or any excipient
History of hypersensitivity to durvalumab, tremelimumab, SGI-110, or any excipient
History of hypersensitivity to durvalumab, tremelimumab, or any excipient.
Hypersensitivity to any of the investigational agents under test, or any excipient of these products
Have known hypersensitivity to the active substance or to an excipient of the study treatments.
History of hypersensitivity to durvalumab (MEDI4736), tremelimumab, or any excipient
History of hypersensitivity to durvalumab, tremelimumab, olaparib or, any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to MEDI4736 or any excipient
History of hypersensitivity to durvalumab or tremelimumab or any excipient
History of hypersensitivity to MEDI4736 or any excipient.
History of hypersensitivity to durvalumab or any excipient.
History of hypersensitivity to durvalumab, guadecitabine (SGI-110) or any excipient
History of hypersensitivity to durvalumab or any excipient
Have known hypersensitivity to the active substance or to an excipient for a study treatment.
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab, tremelimumab or any excipient
History of hypersensitivity to durvalumab or any excipient
Known hypersensitivity to any component of the investigational product (PVX-410, durvalumab, or any excipient)
History of hypersensitivity to durvalumab or any excipient
History of hypersensitivity to durvalumab or any excipient
Have known hypersensitivity to anthracycline compounds or any excipient in NC-6300.
History of hypersensitivity to durvalumab, tremelimumab or any excipient
